Conservative Management of Postsurgical Chylothorax with Octreotide
- 1 September 2005
- journal article
- research article
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 13 (3) , 222-224
- https://doi.org/10.1177/021849230501300306
Abstract
Postsurgical chylothorax after lung resection has an important associated rate of morbidity and mortality, and a large proportion of cases require re-exploration. The most desirable and least aggressive option is conservative treatment. The use of octreotide seems to be associated with a higher rate of resolution without the need for surgical intervention. We present 4 cases in which this drug showed excellent efficacy and minimal adverse effects in the resolution of postsurgical chylothorax.Keywords
This publication has 7 references indexed in Scilit:
- Octreotide to treat postoperative chylothorax after cardiac operations in childrenThe Annals of Thoracic Surgery, 2001
- Current management of postoperative chylothoraxThe Annals of Thoracic Surgery, 2001
- Conservative management of postoperative chylothorax using somatostatinThe Annals of Thoracic Surgery, 2000
- Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in childrenThe Annals of Thoracic Surgery, 1999
- Treatment of a persistent postoperative chylothorax with somatostatinThe Annals of Thoracic Surgery, 1998
- Postpneumonectomy chylothoraxThe Annals of Thoracic Surgery, 1993
- Postoperative chylothorax in children: Differences between vascular and traumatic originJournal of Pediatric Surgery, 1991